Doak’s proven track record in driving growth through partnerships with public-sector entities and global organizations will spur global expansion for NTx

Nature’s Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the appointment of William (Bill) Doak as Vice President, Global Government Programs. In this role, Mr. Doak will guide NTx’s global government programs in the biomaterials and life sciences manufacturing sectors and oversee compliance and strategic risk management.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250128161687/en/

William (Bill) Doak has joined NTx as Vice President, Global Government Programs. In this role, Mr. Doak will guide NTx’s global government programs in the biomaterials and life sciences manufacturing sectors. (Photo: Business Wire)

Mr. Doak brings impressive depth and expertise in building relationships that generate new business through government relations and public-private collaboration to NTx. Most recently, Mr. Doak spent eight years with Amazon Web Services (AWS) as Global Partner Leader, Professional Services, where he expanded the Professional Services capability for the public sector and improved profitability of Professional Services engagements. He also served as the Head of Professional Services, Public Sector, Asia-Pacific & Japan for AWS in Singapore where he built a brand new multi-million public sector business that served government, education, healthcare, and nonprofit organizations. Earlier in his career, Mr. Doak spent nearly two decades working for IBM in various life sciences consulting and public sector management roles across the Asia-Pacific region and the Middle East.

“Mr. Doak’s expertise across regulatory affairs, government relations, and global program management will be key to growing our business with government entities in the U.S. and abroad. We look forward to continuing to build a coalition of organizations that have a vested interest in improving public health through the development of vaccines and therapeutics,” said Dr. Jamie Coffin, President and CEO of NTx. “Over the course of his career, he has led major initiatives for some of the world’s most well-known organizations, which will be invaluable to NTx as he builds a team of government relations and regulatory professionals to manage new international stakeholders. This strategic addition to the team underscores NTx's commitment to advancing global health through biomanufacturing innovation that powers the future of medicine.”

NTx’s proprietary technologies are shaping the future of medicine by enhancing the speed, scalability, and precision of mRNA and biomaterial production. These innovations are not only meeting urgent healthcare needs but also redefining how vaccines and therapeutics are developed and delivered worldwide.

“NTx’s technology has the ability to close major gaps in scalability and efficiency within biomanufacturing for the development of new personalized medicines and therapeutics,” said Bill Doak. “I am excited to leverage my expertise and help grow the company’s network of international stakeholders as it enters a new phase of commercialization where relationships with government officials across the globe will be critical.”

About NTx

Nature’s Toolbox, Inc. (NTx), based in Rio Rancho, New Mexico, is revolutionizing biomanufacturing with cutting-edge solutions tailored to the demands of modern research and personalized medicine. NTx is developing innovative systems like NTxscribe® and NTxpress® to enable the sustainable production of mRNA and protein therapeutics, offering scalability from personalized doses to mass-market volumes. Discover how NTx is shaping the future of medicine at www.ntxbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250128161687/en/